Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-000618
Filing Date
2025-01-31
Accepted
2025-01-31 18:28:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 6882
2 SCHEDULE A p25-0359schedulea.htm EX-99 7067
  Complete submission text file 0000902664-25-000618.txt   15801
Mailing Address 399 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-418-2100
EMINENCE CAPITAL, LP (Filed by) CIK: 0001107310 (see all company filings)

EIN.: 134036527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 8145 BLAZER DRIVE WILMINGTON DE 19808
Business Address 8145 BLAZER DRIVE WILMINGTON DE 19808 304-995-3000
ASHLAND INC. (Subject) CIK: 0001674862 (see all company filings)

EIN.: 812587835 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89658 | Film No.: 25579905
SIC: 5160 Wholesale-Chemicals & Allied Products
(CF Office: 07 Trade & Services)